This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novozymes Biopolymer Ais. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Kristoffer Toemmeraas: Innovator in Hyaluronic Acid Technology
Introduction
Kristoffer Toemmeraas is a notable inventor based in Malmo, Sweden. He has made significant contributions to the field of biopolymers, particularly in the development of branched hyaluronic acid. His innovative work has led to advancements in various applications, showcasing his expertise and dedication to research.
Latest Patents
Toemmeraas holds a patent for a branched hyaluronic acid and its method of manufacture. This patent describes a branched hyaluronic acid where the linear backbone consists of hyaluronic acid, with one or more N-Acetyl-Glucosamine deacetylated to Glucosamine. The invention includes branching sidechains covalently linked to the primary amines of the deacetylated Glucosamine, forming secondary amines. This technology serves as a precursor for producing branched hyaluronic acid and outlines a method for its production.
Career Highlights
Kristoffer Toemmeraas is currently employed at Novozymes Biopolymer A/S, where he continues to push the boundaries of biopolymer research. His work at Novozymes has allowed him to collaborate with leading experts in the field and contribute to innovative solutions in biopolymer applications.
Collaborations
Toemmeraas works alongside Khadija Schwach-Abdellaoui, with whom he shares insights and expertise in their research endeavors. Their collaboration exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in technology.
Conclusion
Kristoffer Toemmeraas is a pioneering inventor whose work in branched hyaluronic acid has the potential to impact various industries. His dedication to innovation and collaboration highlights the importance of research in advancing biopolymer technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile